Relationship between allergic rhinitis and bronchialasthma



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of the review is to discuss different aspects and mechanisms of the relationship between allergic rhinitis and asthma. Therapeutic strategy has to include the treatment of both diseases. Modern treatment of allergic rhinitis may improve control of concomitant asthma.

About the authors

A V Emelianov

St.-Petersburg postgraduate Education Academy

Email: emelav@inbox.ru
St.-Petersburg postgraduate Education Academy

T E Elizarova

p. Pavlov state medical University, st.-petersburg

p. Pavlov state medical University, st.-petersburg

G R Sergeeva

St.-Petersburg postgraduate Education Academy

St.-Petersburg postgraduate Education Academy

References

  1. Bousquet J., van Cavuwenberge P., Khaltaev N. et al. Allergic rhinitis and its impact on asthma (ARIA). Pocket Guide-WHO. 2001, 23 p.
  2. Bousquet J., Khaltaev N., Cruz A. et al. Allergic rhinitis and its impact on asthma (ARIA) update 2008 (in collaboration with World Health Organization, GA2LEN and AllerGen). Allergy. 2008, v. 63, suppl. 86, р. 8-160.
  3. Сергеева Г.Р. Бронхиальная астма и аллергический ринит в Санкт-Петербурге (распространенность и подходы к совершенствованию специализированной помощи взрослому населению). Автореферат диссертации канд. мед. наук. СПб. 2003, 24 с.
  4. Brozek J., Jean Bousquet, Carlos E. Baena-Cagnan et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J. Allergy Clin. Immunol. 2010, v. 126, p. 466-476.
  5. Leynaert B., Neukirch F., Demoly P., Bousquet J. Epidemiologic evidence for asthma and allergic rhinitis. J. Allergy Clin. Immunol. 2000, v. 106, р. 201-205.
  6. Settipane G., Settipane R.J., Hagy G.W Long term risk factors for developing asthma and allergic rhinitis: a 23 year follow up study of college students. Allergy Proc. 1994, v. 15, p. 15-21.
  7. Leynaert B., Bousquet J., Neukirch C. et al. Perennial rhinitis: an indepеndent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey J. Allergy Clin. Immunol. 1999, v. 104, pt. 1, p. 301-304.
  8. Togias A. Mechanisms of nose-lung interaction. Allergy. 1999, v. 54, suppl. 57, p. 94-105.
  9. Sampaio F., Proud D., Leopold D. et al. Asthmatics with rhinosinusitis have worse upper airway disease compared to patients with rhinosinusitis alone (abstract). ACI International. 1997, suppl. 4, p. 136.
  10. Gutierrez V., Prieto L., Torres V. et al. Peak flow variability and sputum eosinophilia in allergic rhinitis. Ann. Allergy Asthma Immunol. 1998, v. 81, p. 143-150.
  11. Polosa R., Ciamarra I., Mangano G. et al. Bronchial hyperre-sponsiveness and airway inflammation markers in nonasthmat-ics with allergic rhinitis. Eur. Respir. J. 2000, v. 15, p. 30-35.
  12. Alvaretz M.J., Olaguibei J.M., Gracia B.E. et al. Comparison of allergen-induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients. Allergy. 2000, v. 55, p. 531-539.
  13. Chakir J., Laviolette M., Turcotte H. et al. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J. Allergy Clin. Immunol. 2000, v. 2000, p. 904-910.
  14. Braunstahl G.J., Overbeek S.E., Kleinjan A. et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J. Allergy Clin. Immunol. 2001, v. 107, p. 469-476.
  15. Gaga M., Lambrou P., Papageorgiou N. et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin. Exp. Allergy. 2000, v. 30, p. 663-669.
  16. Braunstahl G.J., Kleinjan A., Overbeek S.E. et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am. J. Respir. Crit. Care. Med. 2000, v. 161, p. 2051-2057.
  17. Durham S.R. Effect of intranasal corticosteroid treatment on asthma in children and adults. Allergy. 1999, v. 54, suppl. 57, p. 124-131.
  18. Howarth P.H. Seasonal and perennial allergic rhinitis. Asthma and Allergic Rhinitis. Evolving Concepts in Management/Ed. B. Kay.-Black Science. 1998, p. 15-30.
  19. Togias A. Unique mechanistic feature of allergic rhinitis. J. Allergy Clin. Immunol. 2000, v. 105, pt. 2, р. 599-604.
  20. White M. Mediators of inflammation and the inflammatory process. J. Allergy Clin. Immunol. 1999, v. 103, р. 378-381.
  21. Durham S.R. The inflammatory nature of allergic diseases. Clin. Exp. Allergy. 1998, v. 28, suppl. 6, p. 20-24.
  22. Fireman F. Allergic rhinitis. В кн. Atlas of allergies. Ed. P. Fireman, R.G. Slavin, 2 Ed., Mosby-Wolf. 1999, p. 141-160.
  23. Rajakulsingam K., Anderson D.F., Holgate S. Allergic rhinitis, nonallergic rhinitis and ocular allergy. В кн. Allergy, Ed. A.P Kaplan, 2 Ed. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo. W.B. Sauders Company. 1997, p. 421-448.
  24. Howarth P.H. Pathogenic mechanisms: a rational basis for treatment. Brit. Med. J. 1998, v. 316, p. 758-761.
  25. Ricca V., Landi M., Ferrero P. et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 2000, v. 105, p. 54-57.
  26. Ciprandi G., Buscaglia S., Persce et al. Minimal persistent inflammation is present at mucosal level in asymptomatic rhinitis patients with allergy due to mites. J. Allergy Clin. Immunol. 1995, v. 96, p. 971-979.
  27. Greeve J.M., Davies G., Meyer A.M. et al. The major human rhinovirus receptor is ICAM-1. Cell. 1989, v. 56, p. 839.
  28. Passalacqua G., Ciprandi G., Canonica G.W. The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Cur. Opin. Allergy Clin. Immunol. 2001, v. 1, p. 1-7.
  29. Simons F.E.R. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J. Allergy Clin. Immunol. 1994, v. 104, p. 534-540.
  30. Bousquet J., Lockey R.F., Malling H.-J. et al. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998, v. 53, suppl. 30 p.
  31. Van Cauwenberg P., Bachert C., Passalacqua G. et al. Consensus statement on the treatment of allergic rhinitis. Allergy. 2000, v. 55, p. 116-129.
  32. Global Initiative for Аsthma. NHLB/WHO Workshop Report. National Heart Lung Blood Institute, Publication number 02-3659, revised 2006. Пер. с англ. М., Атмосфера. 2007, 103 c.
  33. Corren J., Harris A., Aaronson D. et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J. Allergy Clin. Immunol. 1997, v. 100, p. 781-788.
  34. Ciprandi G., Buscaglia S., Persce et al. Minimal persistent inflammation is present at mucosal level in asymptomatic rhinitis patients with allergy due to mites. J. Allergy Clin. Immunol. 1995, v. 96, p. 971-979.
  35. Adams R.J., Fuhlbrigge A.L., Finkelstein J.A., Weiss S.T Intranasal steroids and the risk of the emergency department visits for asthma. J. Allergy Clin. Immunol. 2002, v. 109, p. 636-642.
  36. Corren J., Manning B.E., Thompson S.F. Rhinitis therapy and the prevention of hospital care for asthma: a case control study J. Allergy Clin. Immunol. 2004, v. 113, p. 415-419.
  37. Crystal-Peters J., Neslusan C., Crown W.H., Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalization and emergency room visits. J. Allergy Clin. Immunol. 2002, v. 109, p. 57-62
  38. Derendorf H., Meltzer E.O. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008, v. 63, p. 1292-1300.
  39. Penagos M., Complati E., Tarantini F. et al. Efficacy of mometasone furoate nasal spray in the traetment of allergic rhinitis. Meta-analysis of randomized, double blind, placebo- controlled, clinical trials. Allergy. 2008, v. 63, p. 1280-1291.
  40. Елизарова Т.Е. Оценка взаимосвязи аллергического ринита и бронхиальной астмы. Автореферат диссертации канд. мед. наук. СПб. 2004, 15 с.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2009



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies